Skip Navigation



IJE Advance Access published online on November 4, 2007

International Journal of Epidemiology, doi:10.1093/ije/dym217
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
37/3/481    most recent
dym217v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Næss, O.
Right arrow Articles by Aamodt, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Næss, O.
Right arrow Articles by Aamodt, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association. © The Author 2007; all rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

Cohort Profile: Cohort of Norway (CONOR)

Øyvind Næss1,2,3,*, Anne Johanne Søgaard1,2, Egil Arnesen4, Anne Cathrine Beckstrøm2, Espen Bjertness2, Anders Engeland5, Peter F Hjort2, Jostein Holmen6,7, Per Magnus1,2, Inger Njølstad4, Grethe S Tell5, Lars Vatten7, Stein Emil Vollset5 and Geir Aamodt1

1Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway.
2Institute of General Practice and Community Medicine, Medical Faculty, University of Oslo, Oslo, Norway.
3Institute of Health Management and Health Economics, Medical Faculty, University of Oslo, Oslo, Norway.
4Institute of Community Medicine, University of Tromsø, Tromsø, Norway.
5Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway.
6HUNT Research Centre, Institute of Community Medicine, NTNU, Verdal, Norway.
7Institute of Community Medicine, NTNU, Verdal,Norway.

* Corresponding author. Norwegian Institute of Public Health, P.O. Box 4404 Nydalen, 0403 Oslo, Norway. E-mail: oena@fhi.no

Accepted 1 October 2007

The first 150 words of the full text of this article appear below.


    How did the study come about?
 
A number of large population-based cardiovascular surveys have been conducted in Norway since the beginning of the 1970s. The surveys were carried out by the National Health Screening Service in cooperation with the universities and local health authorities. All surveys comprised a common set of questions, standardized anthropometric and blood pressure measurements and non-fasting blood samples that were analysed for serum lipids at the Ullevål Hospital Laboratory. These surveys provided considerable experience in conducting large-scale population-based surveys, thus an important background for the Cohort of Norway (CONOR). In the late 1980s the Research Council of Norway established a programme in epidemiology. This also gave stimulus to the idea of establishing a cohort including both core survey data and stored blood samples. In the early 1990s, all universities, the National Health Screening Service, The National Institute of Public Health and the Cancer Registry discussed the possibility of a national representative cohort.1 . . . [Full Text of this Article]


    The purpose of CONOR
 

    Who is in the sample?
 

    What has been measured?
 
Measures
The CONOR questions
Blood samples

    What has been found?
 

    What are the main strengths and weaknesses?
 

    Can I get hold of the data? Where can I find out more?
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int J EpidemiolHome page
T. Stocks, W. Borena, S. Strohmaier, T. Bjorge, J. Manjer, A. Engeland, D. Johansen, R. Selmer, G. Hallmans, K. Rapp, et al.
Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can)
Int. J. Epidemiol., April 20, 2009; (2009) dyp186v1.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
G. D. Smith
'Something funny seems to happen': J.B.S. Haldane and our chaotic, complex but understandable world
Int. J. Epidemiol., June 1, 2008; 37(3): 423 - 426.
[Full Text] [PDF]